Log Out

Weekly FDA Drug Pipeline Calendar (Oct 10- Oct 13)

BioPharm Insight US wrote a column · Oct 10, 2022 07:49

Weekly FDA Drug Pipeline Calendar (Oct 10- Oct 13)

Announcement Document

$AbbVie(ABBV.US)$: AbbVie Highlights Robust Gastroenterology Portfolio with New Data in Crohn's Disease and Ulcerative Colitis at the UEG Week 2022

$Protagonist Therapeutics(PTGX.US)$: Protagonist Therapeutics Announces Topline Data from Phase 2 IDEAL Study of PN-943 in Ulcerative Colitis

$PTC Therapeutics(PTCT.US)$: Roche to present new data from its expanding neuromuscular disease portfolio at World Muscle Society 2022

$Scholar Rock(SRRK.US)$: Scholar Rock to Present New 24-Month Data from Phase 2 TOPAZ Study at Two International Conferences: World Muscle Society Congress and International Scientific Congress on Spinal Muscular Atrophy

Follow for more insights and top news for pharmacy industry! $The Health Care Select Sector SPDR® Fund(XLV.US)$ $Spdr Series Trust Spdr S&P Pharmaceuticals Etf(XPH.US)$ $Ishares Trust U.S. Pharmaceuticals Etf(IHE.US)$

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

+0

15

1

Translate

Report

61K Views

Comment

Sign in to post a comment

SpyderCall : good stuff. keep it coming

Report
Reply

Cancel Reply

BioPharm Insight US

We are the content provider of Moomoo Courses.

909Followers

8Following

1458Visitors

Follow